Rhythm Pharmaceuticals
Price & Volume
Stats
See moreOpen | $100.53 |
Previous Close | $102.44 |
Day Range | $96.56-$100.53 |
52W Range | $74.50-$122.20 |
Market Cap | $7.2B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $239.9M |
Revenue Growth (YoY) | 46.9% |
Gross Profit (12 Mos) | $213.5M |
Diluted EPS | -$3.12 |
News
See moreYahoo Finance • 20 days ago
Billionaire Stanley Druckenmiller Is Quietly Loading Up on Healthcare Stocks -- Here's What His New Positions Reveal
Yahoo Finance • 23 days ago
Eli Lilly and Novo Nordisk Can't Treat This Form of Obesity. Billionaire Stanley Druckenmiller Is Betting Rhythm Pharmaceuticals Can
Yahoo Finance • last month
Rhythm Pharmaceuticals GAAP EPS of -$0.73 beats by $0.09, revenue of $71.26M beats by $3.6M
Yahoo Finance • last month
Rhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
About
CEO | Dr. David P. Meeker M.D. |
CFO | Mr. Hunter C. Smith M.B.A. |
Address | 222 Berkeley Street, Boston, MA, United States, 02116 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 414 |